Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03922165 · ClinicalTrials.gov registry record
Healthy Sleep for Children With Down Syndrome
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 26
- Enrollment target
NCT03922165: Completed study, sponsored by Brigham and Women's Hospital.
NCT03922165 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03922165 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The purpose of this multi-center observational study (utilizing the sites enrolling patients for the Pediatric Adenotonsillectomy Trial for Snoring (PATS) \[1U011HL125307-O1A1\]) is to gather data regarding children with Down syndrome (DS) and Sleep Disordered Breathing (SDB) referred for treatment with adenotonsillectomy to inform a future randomized controlled trial in this population.
Primary Outcome
Percentage of families approached for participation that sign informed consent to participate.
Interventions
- PROCEDURE Adenotonsillectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-05-22 |
| Est. Completion | 2021-12-31 |
What the finished NCT03922165 record still lists
NCT03922165 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Adenotonsillectomy is the first listed.
NCT03922165 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03922165 about?
NCT03922165 is a clinical study titled "Healthy Sleep for Children With Down Syndrome". The purpose of this multi-center observational study (utilizing the sites enrolling patients for the Pediatric Adenotonsillectomy Trial for Snoring (PATS) \[1U011HL125307-O1A1\]) is to gather data regarding children with Down syndrome (DS) and Sleep Disordered Breathing (SDB) referred for treatment ...
What is the current status of trial NCT03922165?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2019-05-22. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03922165?
The interventions under investigation include: Adenotonsillectomy (PROCEDURE).
Who is sponsoring clinical trial NCT03922165?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI